Position in ZTS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$42,282,277
-$30,428,570 QoQ
Shares Held
588,398
-4.3% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#97
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Mar 31, 2025CallValue
$3,852,810
CallShares
23,400
PutValue
$3,852,810
PutShares
23,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $180,170,999 across 30 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
588,398 | $42,282,277 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
971,583 | $32,917,229 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
776,464 | $26,920,005 | |
| 4 | VTRS |
Viatris Inc
|
1,275,750 | $20,258,907 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
224,707 | $18,601,244 | |
| 6 | HLN |
Haleon plc
|
908,864 | $8,479,699 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
13,342 | $7,229,093 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
35,697 | $6,016,371 |
All Filings in ZTS
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,282,277 | 588,398 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $72,710,847 | 615,099 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $71,260,920 | 566,372 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $102,170,130 | 698,265 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $121,850,124 | 781,341 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $3,852,810 | 23,400 | Call | Defined | 2025-05-13 | |
| 2025-03-31 | $126,910,569 | 770,790 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $3,852,810 | 23,400 | Put | Defined | 2025-05-13 | |
| 2024-12-31 | $135,795,472 | 833,459 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $192,372,316 | 984,606 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $194,359,268 | 1,121,131 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $189,091,157 | 1,117,494 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $196,546,371 | 995,827 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $174,118,312 | 1,000,795 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $159,269,792 | 924,858 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $89,198,024 | 535,917 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $84,431,409 | 576,127 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $76,422,138 | 515,356 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $97,662,393 | 568,168 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $130,449,020 | 691,707 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $239,536,185 | 981,585 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $187,498,272 | 965,789 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $188,925,241 | 1,013,765 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $88,978,087 | 565,012 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $102,115,815 | 617,014 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $74,143,470 | 448,349 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $66,566,903 | 485,748 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $72,128,313 | 612,867 | Shares | Defined | 2020-05-13 | |
| 2020-03-31 | $553,143 | 4,700 | Call | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||